Gestationsdiabetes – die wichtigsten neuen klinisch relevanten Aspekte

Zusammenfassung

Die Aufnahme des Screenings auf Gestationsdiabetes (GDM) in die deutschen Mutterschafts-Richtlinien 2012 und die Publikation einer Vielzahl von neuen Studien führen zu klinikrelevanten Änderungen in der Versorgung der Schwangeren mit GDM, die in der im März dieses Jahres erschienenen neuen S3-Leitlinie zur Diagnostik, Therapie und Nachsorge bei Gestationsdiabetes (AWMF 057/008) berücksichtigt wurden. Einige Aspekte werden dargestellt und auf der Basis von weiteren Hintergrundinformationen diskutiert.

Schlüsselwörter

foetal period - gestational diabetes - metabolic defects

• References/Literatur

• 1 Melchior H, Kurch-Bek D, Mund D. The prevalence of gestational diabetes – a population-based analysis of a nationwide screening program. Dtsch Ärzteblatt Int 2017; 114: 412-416
• 2 Prutsky GJ, Domecq JP, Sundaresh V. et al. Screening for gestational diabetes: A systematic review and meta-analysis. J Clin Endocrinol Metab 2013; 98: 4311-4318
• 3 Metzger BE, Dyer AR. Comment on dʼEmden. Do the new threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk?. Diabetes Care 2014; 37: 43-44
• 4 Benhalima K, Van Crombrugge P, Moyson C. et al. The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 WHO Health organisation criteria. Diabetes Care 2018; 41: e111-e112 doi:10.2337/dc18-0556
• 5 Farrar D, Duley L, Dowswell T. et al. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2017; (08) CD007122
• 6 Tieu J, McPhee AJ, Crowther CA. et al. Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health. Cochrane Database Syst Rev 2017; (08) CD007222
• 7 McIntyre HD, Jensen DM, Jensen RC. et al. Gestational Diabetes Mellitus: Does One Size Fit All? A Challenge to Uniform Worldwide Diagnostic Thresholds. Diabetes Care 2018; 41: 1339-1342 doi:10.2337/dc17-2393
• 8 Zhu WW, Yang HX, Wei YM. et al. Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China. Diabetes Care 2013; 36: 586-590
• 9 Nauck M, Petermann A, Müller-Wieland D. et al. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie und Stoffwechsel 2017; 12 (S02): S94-S100
• 10 Immanuel J, Simmons D. Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis. Curr Diab Rep 2017; 17: 115
• 11 Butalia S, Gutierrez L, Lodha A. et al. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med 2017; 34: 27-36
• 12 Rowan JA, Rush EC, Obolonkin V. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011; 34: 2279-2284
• 13 Tertti K, Eskola E, Ronnemaa T. et al. Neurodevelopment of Two-Year-Old Children Exposed to Metformin and Insulin in Gestational Diabetes Mellitus. J Dev Behav Pediatr 2015; 36: 752-757
• 14 Wouldes TA, Battin M, Coat S. et al. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed 2016; pii:fetalneonatal-2015-309602
• 15 Society of Maternal-Fetal Medicine (SMFM) Publications Committee. Electronic address: [e-mail]. SMFM Statement: Pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018; 218: B2-B4
• 16 Rowan JA, Rush EC, Plank LD. et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age. BMJ Open Diabetes Res Care 2018; 6: e000456 doi:10.1136/bmjdrc-2017-000456
• 17 Niu B, Lee VR, Cheng YW. et al. What is the optimal gestational age for women with gestational diabetes type A1 to deliver?. Am J Obstet Gynecol 2014; 211: 418.e1-418.e6
• 18 Sutton AL, Mele L, Landon MB. et al. Delivery timing and cesarean delivery risk in women with mild gestational diabetes mellitus. Am J Obstet Gynecol 2014; 211: 244.e1-244.e7
• 19 Boulvain M, Senat MV, Perrotin F. et al. Induction of labour versus expectant management for large-for-date fetuses: A randomised controlled trial. Lancet 2015; 385: 2600-2605
• 20 Schäfer-Graf U, Gembruch U, Hösli I. et al. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge. Online: https://www.awmf.org/leitlinien/detail/ll/057-008.html Last access: 18.08.2018